Paul L. Berns, Director at Jazz Pharmaceuticals plc (JAZZ), sold 1,862 shares at $125.87 ($234K) on 2020-08-07, disclosed to the SEC on 2020-08-10.
Seasonal sale ($234k) by Director — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $125.87 | 931 | $117K | 50.0% |
| 2 | $125.87 | 931 | $117K | 50.0% |
| Total | $125.87 avg | 1,862 | $234K | 100% |
| Filing → |
| NMRA | SELL | 2026-02-19 | $34K | — | Filing → |
| NMRA | SELL | 2025-02-20 | $23K | — | Filing → |
| MTSR | BUY | 2025-02-03 | $14.2M | — | Filing → |